Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naoxin'an capsule for cognitive dysfunction after ischemic stroke
ChiCTR2100046757Phase 4Recruiting
- Sponsor
- Institute of Basic Research in Clinical Medicine
- Start
- Jun 2021
- Countries
- 1
01
Overview
Phase 4 trial of naoxin'an capsule in ischemic stroke and confusion (2 arms), sponsored by Institute of Basic Research in Clinical Medicine. Primary endpoints: Auditory Verbal Learning Test at 6 months and Alzheimer's Disease Rating Scale - Cognitive Part at 6 months. Started Jun 2021; status: recruiting.
02
Drugs
naoxin'an capsule
03
Conditions
ischemic strokeconfusion
Beyond the preview
Go deeper on ChiCTR2100046757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046757.